,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny04', 'bcsm']
what an exciting moment to be part of the standing ovation for destiny04 at #asco22 #bcsm 
Hematology/Oncology Fellow @MountSinaiNYC